Introduction: Human umbilical cord mesenchymal stem cells (HUC-MSCs) are one of the
typical adult stem cells; they have superiorities including low immunogenicity, non-invasive …

Mesenchymal stem cells (MSCs) are being increasingly investigated as a therapeutic
alternative, not only for their possible regenerative potential but also for their …

Despite excellent short-term results, long-term survival of transplanted kidneys has not
improved accordingly. Although alloimmune responses and calcineurin inhibitor-related …

Mesenchymal stem (stromal) cells (MSCs) have potent anti‐inflammatory/
immunosuppressive properties which underlie much of their therapeutic potential. This fact …

Lifelong immunosuppressive therapy is essential to prevent allograft rejection in transplant
recipients. Long-term, nonspecific immunosuppression can, however, result in life …

Bone marrow (BM)-derived mesenchymal stromal cells (MSCs), endowed with
immunosuppressive and anti-inflammatory properties, represent a promising tool in …

The prevalence of kidney diseases is emerging as a public health problem. Stem cells
(SCs), currently considered as a promising tool for therapeutic application, have aroused …

The ultimate goal in transplantation medicine is the promotion of operational tolerance.
Although Th cells of the Th17 type have been predominantly associated with rejection of …

Bone marrow‐derived mesenchymal stromal cells (MSC) have emerged as useful cell
population for immunomodulation therapy in transplantation. Moving this concept towards …

The corneal functions (transparency, refractivity and mechanical strength) deteriorate in
many corneal diseases but can be restored after corneal transplantation (penetrating and …